Insulin resistance is a common problem that is associated with obesity and hypertension, infection and injury, and type 2 diabetes, in which ␤-cells fail to secrete sufficient insulin to compensate for peripheral insulin resistance (1) (2) (3) . Insulin signaling complexes are assembled by insulin-stimulated tyrosine phosphorylation of scaffold proteins, including the Irs1 1 proteins, Shc, APS and Shc, Gab1/2, Dock1/2 and cbl (4 -6) . Although the role of each of these substrates merits attention, work with transgenic mice reveals the importance of Irs1 and Irs2 for somatic growth and carbohydrate metabolism (7, 8) . Tyrosine phosphorylation sites in Irs1 and Irs2 bind to the Src homology-2 domain in various signaling proteins that mediate the insulin response, including PI 3-kinase, Grb2, Shp2, Crk, and others (9) .
A number of mechanisms might contribute to the dysregulation of the insulin-signaling pathway, including serine phosphorylation of the insulin receptor or the Irs proteins, degradation of Irs proteins, or altered activity of phosphoprotein or phospholipid phosphatases (10 -16) . Irs1 and Irs2 contain many potential serine or threonine phosphorylation sites that might play regulatory roles during the insulin response. Various metabolites associated with insulin resistance stimulate serine phosphorylation of Irs1, including free fatty acids, diacylglycerol, fatty acyl CoAs, ceramides, and glucose (17) . Moreover, proinflammatory cytokines, especially interferon ␥, interleukin 1␤, or TNF␣ produced during infection, injury, or chronic obesity stimulate serine phosphorylation of Irs1 and cause insulin resistance (18, 19) . Insulin itself induces serine phosphorylation of Irs1, suggesting that chronic compensatory hyperinsulinemia in response to stress-induced insulin resistance might exacerbate the problem (20) .
More than 100 potential serine phosphorylation sites exist in Irs1, and many protein kinases phosphorylate Irs1, including JNK, protein kinase C, IKK␤, mammalian target of rapamycin, MAPK, and AMPK (11) (12) (13) (21) (22) (23) ; however, the kinases and phosphorylation sites that are physiologically important for Irs1 function are difficult to resolve. Although many kinases phosphorylate Irs1, JNK is especially interesting because it associates with Irs1 and phosphorylates Ser 307 (11, 20) . Insulin also stimulates Ser 307 phosphorylation in various cultured cell lines; and the orthologous site in human Irs1 (Ser 312 ) is phosphorylated in muscle during a hyperinsulinemic clamp (24) . Ser 307 is located next to the phosphotyrosine-binding domain in Irs1, and its phosphorylation inhibits the interaction of the phosphotyrosine-binding domain with the phosphorylated NPEY motif in the activated insulin receptor (20) . Because the phosphotyrosine-binding domain is important for efficient insulin-stimulated tyrosine phosphorylation of Irs1, Ser 307 phosphorylation might contribute to insulin resistance during physiological stress.
JNK is a member of the MAP kinase family of protein kinases, which also includes ERK and p38 (25, 26) . JNK is activated by proinflammatory cytokines induced during microbial infection or thermal or mechanical injury (27, 28) . Three JNK isoforms, JNK1, JNK2, and JNK3, are expressed in multiple splice variants (29) . Disruption of these genes in mice reveals that JNK1 and JNK2 mediate T cell activation and brain development (30 -32) , and JNK3 mediates neuronal apo-ptosis in the hippocampus (33) . Various growth factors also activate JNK, including prolactin, epidermal growth factor, nerve growth factor and platelet-derived growth factor, insulinlike growth factor 1, and ligands for some G protein-coupled receptors (34 -40) . Insulin stimulates JNK in various cells and tissues, but the mechanisms involved and the role of JNK during insulin action are poorly defined (41) (42) (43) . Here we show that insulin-stimulated JNK associates with Irs1 and phosphorylates Ser 307 , which inhibits insulin signaling. Thus, JNK might serve a dual function as a heterologous inhibitor of insulin action during acute and chronic inflammation and as a feedback inhibitor during insulin stimulation. ) were purchased from New England Biolabs. Monoclonal antibodies against JNK and phospho-c-Jun (pSer 63 ) were purchased from Santa Cruz. Phosphotyrosine antibody (PY20) was purchased from Transduction Laboratories. Antibodies against Irs1 and phosphorylated Ser 307 in Irs1 were described previously (20, 24) . Insulin was purchased from Roche Molecular Biochemicals, and TNF␣ was purchased from R&D Systems. LY294002 and PD98059 were purchased from Calbiochem-Novabiochem Corp. Peptides were synthesized by Boston Biomolecules and purified by high pressure liquid chromatography, and the sequences were confirmed by mass spectrometry.
MATERIALS AND METHODS

Antibodies and Reagents-Antibodies
Cell Culture-Murine myeloid progenitor 32D cells were maintained in RPMI 1640 medium supplemented with 10% FBS, 5% WEHI conditioned medium (as a source of interleukin-3), and 5 mM histidinol and made quiescent by serum starvation for 4 h (20) . 32D transfectants were generated by electroporation and selected in histidinol as described previously (44) ; site-directed mutagenesis of the JNK binding motif in Irs1 was described previously (20) . Mouse embryo fibroblasts from wild type or JNK1::JNK2 knockout mice were grown in DMEM with 10% FBS (45) . 3T3-L1 preadipocytes were maintained at 37°C in 10% CO 2 in DMEM containing 2 mM glucose and 10% calf serum. These cells were differentiated into adipocytes by incubation for 3 days in DMEM supplemented with 25 mM glucose, 1 M insulin, 0.5 mM 3-isobutylmethylxanthine, 1 M dexamethasone, and 10% FBS and 3 days in DMEM supplemented with 1 M insulin and 10% FBS (46) . More than 90% differentiation was achieved after 4 -9 days in DMEM containing 25 mM glucose and 10% FBS with no other additives.
Cell Lysis, Immunoprecipitation, and Western Blot Analysis-Cells were lysed in 20 mM Tris (pH 7.4) containing 150 mM NaCl, 1% Nonidet P-40, 5 mM EDTA, 10 mM NaF, 10 mM pyrophosphate, 100 M NaVO 4 , 1 mM phenylmethanesulfonyl fluoride, 5 g/ml leupeptin, and 5 g/ml protinin. Lysates were resolved by SDS-PAGE, transferred to nitrocellulose, and proteins were detected by immunoblotting and chemiluminescence (Amersham Biosciences). To analyze the association of Irs1 with JNK in 32D cells, immunoprecipitation was performed with Irs1 antibody immobilized on protein G-Sepharose using a Seize™ X protein G immunoprecipitation kit (Pierce) and analyzed by immunoblotting with monoclonal JNK antibody. For 3T3-L1 adipocytes, immunoprecipitates with monoclonal JNK antibody were analyzed by immunoblotting with Irs1 antibody.
2-Deoxyglucose Uptake in 3T3-L1 Adipocytes-Fully differentiated 3T3-L1 adipocytes were placed in DMEM containing 5 mM glucose and 0.1% bovine serum albumin for 2 h at 37°C. Before glucose transport measurements, cells were washed with KRH buffer (20 mM HEPES (pH 7.4) 1.25 mM MgSO 4 , 1.25 mM CaCl 2 , 136 mM NaCl, 4.7 mM KCl, and 0.1% bovine serum albumin) and incubated with synthetic peptides before insulin stimulation. Glucose transport was determined by the addition of 0.1 mM 2-deoxyglucose containing 0.5 Ci of 2-[1, 2- 3 H]-deoxy-D-glucose (PerkinElmer Life Sciences) as described previously (47) . Nonspecific uptake was assessed in the presence of 10 M cytochalasin B and subtracted from all of the measured values. Glucose transport experiments were terminated after 10 min by aspiration by four washes with ice-cold phosphate-buffered saline. Cells were lysed in 0.1% SDS in phosphate-buffered saline, and radioactivity was determined by scintillation counting.
RESULTS
Irs1
Is Necessary for the Insulin-induced Activation of JNK-We used 32D cell lines stably expressing the human insulin receptor alone or with rat Irs1 to determine the function of insulin-stimulated JNK. 32D cells are murine myeloid progenitors that express few endogenous insulin receptors and no Irs proteins and require interleukin-3 for growth (48) ; however, they naturally express JNK1 and JNK2 (data not shown). JNK1 and JNK2 are activated by tandem Thr/Tyr phosphorylation (Thr 183 and Tyr 185 in JNK1), which is detected in both isoforms by immunoblotting with a phosphospecific-JNK antibody (␣JNK PI ). Both JNK homologs are variably expressed as two alternative transcripts that yield a 46-kDa and a 54-kDa isoform that are detected by ␣JNK PI . In this report we do not distinguish between the homologs.
Before insulin stimulation, JNK phosphorylation was not detected by ␣JNK PI , suggesting that under basal conditions JNK was not activated. However, the 46-and 54-kDa isoforms of JNK were phosphorylated 5 min after insulin was added to the 32D IR /Irs1 cells (Fig. 1A) . JNK phosphorylation was maximal at 10 nM insulin in 32D IR /Irs1 cells, whereas it was weakly phosphorylated during insulin stimulation of 32D IR cells (Fig.  1B) IR /Irs1 cells. During insulin stimulation, tyrosine-phosphorylated Irs1 activates the PI 3-kinase 3 Pkb/ Akt cascade that can be inhibited by LY294002 and activates the Grb2/Sos/Ras 3 ERK1/2 cascade that can be inhibited by PD98059 (9) . Each compound inhibited insulin-stimulated phosphorylation of the 46-and 54-kDa isoforms of JNK in 32D
IR /Irs1 cells and inhibited JNK-mediated phosphorylation of c-Jun ( Fig. 2A) . Thus, PI 3-kinase and MEK1 mediated JNK activation in insulin-stimulated 32D
IR /Irs1 cells ( Fig. 2A) . Each drug also inhibited by 75% the insulin-stimulated phosphorylation of Ser 307 in Irs1, suggesting that the majority of Ser 307 phosphorylation might be mediated by JNK. However, other insulin-stimulated kinases appear to be involved ( Fig. 2A) .
To confirm that tyrosine phosphorylation of Irs1 was required for activation of JNK by insulin, 32D
IR cells were transfected with F18
Irs1 , a rat Irs1 mutant that lacks all the known tyrosine phosphorylation sites, including those that activate the PI 3-kinase and ERK pathways (48) . Consistent with the inhibitory effect of LY294002 or PD98059 on JNK phosphorylation, insulin failed to stimulate JNK phosphorylation in 32D IR /F18 Irs1 cells (Fig. 2B) . Insulin-stimulated phosphorylation of Ser 307 was also significantly reduced. However, like inhibition by LY294002 or PD98059, a minor pathway independent of Irs1 tyrosine phosphorylation might be involved (Fig. 2B) . MEFs. However, transient Ser 307 phosphorylation was detected reproducibly after 20 min of insulin stimulation and might represent the JNK-independent pathway (Fig. 3) . Insulin-stimulated tyrosine phosphorylation of Irs1 was increased in the JNK1 Ϫ/Ϫ ::JNK2 Ϫ/Ϫ MEFs. Tyrosine phosphorylation of Irs1 ordinarily declined after 20 min of insulin stimulation in wild type cells; however, it remained high for at least 40 min in JNK1 Ϫ/Ϫ ::JNK2 Ϫ/Ϫ MEFs. Thus, JNK is a major kinase responsible for insulin-induced Irs1 Ser 307 phosphorylation that inhibits insulin-stimulated tyrosine phosphorylation.
Insulin-stimulated Ser 307 Phosphorylation of Irs1 Is Reduced in Mouse Embryo
The Role of the JNK-binding Motif in Irs1-JNK binds specifically to scaffold proteins that mediate its interaction with upstream regulatory kinases and downstream substrates. The consensus amino acid sequence motif that binds to JNK (JNKbinding peptide (JBP)) is best characterized by alignment of JNK-interacting protein 1 (Jip1) and Jip2 (49) . Previous studies reveal that two leucine residues within the JNK-binding motif are essential for JNK binding (49) . Irs1 contains a similar JNK-binding motif, including both leucine residues at positions 856 and 858 (20) . We prepared 32D
IR cells expressing mutant Irs1 proteins that contain glycine substitutions for the leucine residues (Irs1 GSG ) to determine the effect of blocking JNK binding to Irs1 on the activation of JNK and ability to phosphorylate Ser 307 (Fig. 4A) . Insulin stimulated the binding of wild type Irs1 to JNK in 32D IR /Irs1 cells, whereas insulin failed to stimulate this interaction between JNK and Irs1 GSG , confirming that the JNK-binding motif was required (Fig. 4B) .
During insulin stimulation, wild type Irs1 and Irs1 GSG were rapidly tyrosine phosphorylated, but phosphorylation of Irs1 rapidly declined, whereas that of Irs1 GSG was sustained for at least 20 min (Fig. 5A) . Although both Irs1 and Irs1 GSG mediated insulin-stimulated JNK activation, only Irs1 was susceptible to inhibition by Ser 307 phosphorylation (Fig. 5A) . These results reveal that direct binding of JNK to Irs1 was not required for insulin stimulation, whereas direct binding was required for JNK-mediated Ser 307 phosphorylation. Moreover, Irs1
GSG displayed more sensitive and intense tyrosine phosphorylation than wild type Irs1 at every concentration of insulin tested (Fig. 5B) . Consistent with increased tyrosine phosphorylation, Irs1
GSG mediated more phosphorylation of Pkb/ Akt during insulin stimulation (Fig. 5B) . By contrast, the time course of JNK phosphorylation was not significantly affected by the Irs1 GSG mutant, whereas the sensitivity of JNK phosphorylation to insulin might be slightly impaired (Fig. 5B) . These results support the hypothesis that an interaction between JNK and Irs1 was not essential for activation but was required for insulin-stimulated Ser 307 phosphorylation.
Cell-permeable JNK-binding Motif Inhibits Activation of JNK by
Insulin-Insulin stimulated phosphorylation of the 46-kDa JNK isoform in fully differentiated 3T3-L1 adipocytes, which increased its activity as revealed by phosphorylation of c-Jun (Fig. 6) . Consistent with previous results, insulin strongly stimulated Ser 307 phosphorylation of Irs1 in these cells; Irs1 was also tyrosine-phosphorylated during insulin stimulation (Fig. 6) . The effect of Ser 307 phosphorylation on insulin signaling in 3T3-L1 adipocytes was investigated by inhibiting JNK activation with a 12-amino acid peptide composed of the JNK-binding peptide identified in Jip1 (50) . The JNK-binding peptide inhibits competitively the interaction of JNK with regulatory scaffolds or substrates. To facilitate translocation of the JNK-binding peptide (JBP) across the plasma membrane, the 12-amino acid transduction domain from human immunodeficiency virus TAT protein (HIV-TAT) was added to the N terminus (51) . This chimeric peptide, TAT/JBP, was incubated with 3T3-L1 adipocytes for 30 min to disrupt JNK binding before insulin stimulation. TAT/JBP inhibited in a dose-dependent way insulin-stimulated JNK activity as assessed by c-Jun phosphorylation (Fig. 7A) . TAT/JBP also blocked insulin-stimulated binding of JNK to Irs1 (Fig. 7B) .
Inhibition of JNK Activity Reduced Ser 307 Phosphorylation of Irs1 and Enhanced Insulin Signal Transduction and Glucose
Uptake-To investigate the relation between JNK and Irs1, we treated 3T3-L1 adipocytes with the TAT/JBP and analyzed insulin-signaling events. TAT/JBP (20 M) inhibited insulinstimulated JNK activity and suppressed insulin-stimulated Ser 307 phosphorylation of Irs1. Consistent with the inhibitory role of Ser 307 phosphorylation, insulin-stimulated tyrosine phosphorylation of Irs1 increased (Fig. 8A) . TAT/JBP also increased Akt phosphorylation during insulin stimulation (Fig.  8A) . In 3T3-L1 adipocytes, insulin stimulates the uptake of 2-deoxyglucose by translocation of Glut4 to the plasma membrane (52) . As expected, insulin stimulated uptake of 2-deoxyglucose into 3T3-L1 adipocytes. Incubation of 3T3-L1 adipocytes for 30 min with TAT/JBP but not the 12-residue HIV-TAT peptide increased insulin-stimulated glucose uptake (Fig. 8B) . These results are consistent with the conclusion that JNKmediated phosphorylation of Irs1 at Ser 307 inhibits insulin action.
DISCUSSION
Our cell-based experiments reveal that recruitment of active JNK to Irs1 might be a common mechanism for feedback or heterologous inhibition of the insulin signal. JNK is a member of the MAP kinase family, which also includes the extracellular signal-regulated protein kinases (ERK1/2), p38 MAP kinases, and the ERK5 pathway (25) . MAP kinases are activated by dual-specificity MAP kinase kinases that phosphorylate adjacent tyrosine and threonine residues (29) . During insulin stimulation, ERK1 and ERK2 are strongly activated by the dualspecificity kinases MEK1 or MEK2, which are activated when Grb2/Sos bound to Irs1 or Shc activates the Ras 3 Raf cascade (53, 54) ; however, a molecular pathway linking the receptors for proinflammatory cytokines or insulin to JNK is difficult to establish.
JNK activation is best understood during cytokine stimulation, which involves the recruitment of an upstream multilineage kinase, a dual-specificity kinase (MKK4 or MKK7), and JNK into a regulatory complex including JNK-interacting protein Jip1 or Jip2 (49, 55). By contrast, previous studies suggest that insulin stimulates JNK through PI 3-kinase, Ras, or Shp2 (56). These distinct pathways might converge because the per- (57) . In addition, the possibility exists that mTOR phosphorylates Ser 307 . We showed previously that insulin stimulates Ser 307 phosphorylation in 3T3-L1 preadipocytes without activating JNK (24) . Apparently, unknown differences in insulin signaling in preadipocytes disrupt the link between the insulin receptor and JNK, whereas other cell lines including 32D cells, MEF cells, and adipocytes show strong activation of JNK in response to insulin. Differential coupling between the insulin receptor and JNK might play an important role in feedback regulation of the insulin signaling cascade.
JNK has many effects on cellular function because it phosphorylates and activates various transcription factors, including ATF2 and ATFa, c-Jun and JunD, and Elk1 and Sap1 (28) . Although insulin stimulation of JNK might play an important role in gene transcription as revealed in other systems, our results also suggest that JNK-mediated phosphorylation of Ser 307 in rodent Irs1 mediates negative feedback of insulin signaling. Insulin stimulates the binding of activated JNK to Irs1 in 3T3-L1 and 32D IR /Irs1 cells, which attenuates insulinstimulated tyrosine phosphorylation. Consistent with this hypothesis, disruption of the consensus JNK-binding motif in Irs1 significantly reduces the phosphorylation of Ser 307 during insulin stimulation and increases insulin-stimulated tyrosine phosphorylation and Pkb/Akt activation. Moreover, inhibition of JNK activation by incubating 3T3-L1 adipocytes with a permeable TAT/JNK-binding peptide promotes insulin-stimulated glucose uptake. This result is consistent with reduced insulin-stimulated JNK activity and Ser 307 phosphorylation and increased Irs1 tyrosine phosphorylation and Pkb/Akt phosphorylation. Experiments with mouse embryo fibroblasts lacking JNK1 and JNK2 also support these results. The possibility is not excluded that the binding of JNK to Irs1 itself might have some inhibitory effect in addition to Ser 307 phosphorylation, such as competing with other proteins for binding to Irs1. Although our attention for the moment focuses on Ser 307 phosphorylation, additional serine residues might also be involved. Moreover, we have not distinguished between JNK1 or JNK2 in our experiments, because both homologs bind to Irs1 (data not shown).
Insulin resistance and compensatory hyperinsulinemia dysregulate many physiological processes that contribute to lifethreatening metabolic, vascular, and cardiac diseases (58, 59) . Although new drugs are emerging to improve insulin sensitivity, the molecular mechanisms that cause insulin resistance are difficult to establish. The idea that inflammation causes insulin resistance has been known for a long time (60) and is consistent with the idea that anti-inflammatory drugs like high-dose aspirin promote insulin sensitivity (22, 61) . The physiological response to infection, physical or thermal trauma, or obesity invariably involves the production of proinflammatory cytokines like TNF␣ that activate various serine kinases (28) . Considerable evidence suggests that serine phosphorylation of the insulin receptor or the Irs proteins might inhibit insulin signaling and promote insulin resistance (62) . During obesity, adipocytes produce TNF␣, which promotes insulin resistance and stimulates serine phosphorylation of Irs1, whereas disruption of TNFR1 partially restores insulin signaling and glucose tolerance in obese mice (18, (63) (64) (65) (66) . The signaling cascades regulated by TNF␣ are complex and involve many branch points, including the activation of JNK, p38, and the IKK␤ (28) . IKK␤ might also be important because high doses of salicylates that inhibit IKK␤ improve glucose tolerance in obese mice (22, 61) . Salicylates increase insulin-stimulated phosphorylation of IRS proteins in the liver, revealing a potential mechanism for their effect on insulin action; the effect might occur indirectly through other downstream kinases, through NFB-regulated gene expression. or through direct phosphorylation of Irs1 (57) . By contrast, a direct role for JNK to regulate insulin signaling is compelling, because both Irs1 and Irs2 contain a JNK-binding motif. Other kinases might also bind to this motif and with JNK explain, at least in part, insulin resistance that occurs during trauma and obesity.
In summary, JNK mediates feedback inhibition of insulin signaling by phosphorylation of rat/mouse Irs1 at Ser 307 (Ser 312 in human Irs1). In addition to our experiments with 32D IR /Irs1 cells, MEF cells and 3T3-L1 adipocytes, insulin is reported to stimulate JNK activity in Rat-1 fibroblast, Chinese hamster ovary cells overexpressing human insulin receptors, L6 myotubes, and rat adipocytes (41) (42) (43) . These results suggest that activated JNK might be an important negative feedback regulator for insulin signaling, and thus inhibiting JNK or interfering with JNK-Irs1 interaction might be a good therapeutic target to reduce insulin resistance.
